Lung Cancer Trial, Recruiting NCT06262386 Sponsor: Chang Gung Memorial Hospital Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT06262386
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who had cancer that was able to be surgically removed (classified as clinical stage 1a to 3a at the time of diagnosis)
  • People who have already had surgery to remove their tumor

Who may not be able to join:

  • People whose cancer was found to be at an advanced stage (greater than stage 3b or stage 4) after surgery and laboratory testing of the removed tissue
  • People whose cancer was found to be at a very early stage (less than stage 1a1) after surgery and laboratory testing of the removed tissue
  • People who were not able to complete the full course of treatment required by the trial
  • People who were not able to have blood samples taken for a special cell test (which looks for cancer cells in the blood) or attend regular check-up appointments

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ching-Yang Wu, Chang Gung Memorial Hospital

Phone: +886975368204

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 August 2023
Est. completion
31 July 2028

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Accuracy of proposed relapse prediction model; early relapse rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov